Tao Capital Management’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Tao Capital Management’s Portfolio GRNA Stock Details GRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,671,664	Closed	-$802K	–	14
2023 Q2	$802K	Hold	2,671,664	–	–	0.59%	11
2023 Q1	$1.16M	Hold	2,671,664	–	–	0.92%	13
2022 Q4	$3.15M	Hold	2,671,664	–	–	2.37%	11
2022 Q3	$6.2M	Hold	2,671,664	–	–	4.06%	7
2022 Q2	$5.91M	Hold	2,671,664	–	–	4.09%	7
2022 Q1	$25.7M	Buy	+2,671,664	New	+$23.9M	9.38%	5

Tao Capital Management's GRNA Position: Q3 2023 in Review

Tao Capital Management sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q3 2023, closing a stake of 2,671,664 shares — an estimated $802K sold.

Tao Capital Management first reported a position in GRNA in Q1 2022 and held it in 6 quarters. The position peaked at $25.7M in Q1 2022. 0 funds tracked by Wall St. Rank hold GRNA as of Q3 2023.

Tao Capital Management reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q3 2023 after selling out during the quarter.
Tao Capital Management sold 2,671,664 GreenLight Biosciences Holdings, PBC Common Stock shares in Q3 2023, an estimated $802K.
Tao Capital Management first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q1 2022 and held it in 6 quarters.
Tao Capital Management's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $25.7M in Q1 2022.
0 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q3 2023.

Based on Tao Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.